Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
26.47%
Grew
—
—
Shrank
—
1 Year
Score—
Net Growth26.47%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
Jasper Therapeutics Inc fundamental performance
Across Jasper Therapeutics Inc's full reported history, from 2021 to 2025, revenue declined from $ 6M to $ 0.00 and net income went from -$ 30M to -$ 75M. Revenue increased in 20% of the years measured; net income in 20%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.82 | — |
1 Year2025-08-12 | $ 2.85 | -71.09% |
5 Years2021-08-12 | $ 99.30 | -99.17% |
All Time2021-09-24 | $ 151.20 | -99.46% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-09-24 |
|---|---|---|---|---|
| Price | $ 0.82 | $ 2.85 | $ 99.30 | $ 151.20 |
| Return | — | -71.09% | -99.17% | -99.46% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 55M | $ 14M |
| 2025 | $ 0.00 | -$ 75M | $ 28M |
| 2024 | $ 0.00 | -$ 71M | $ 71M |
| 2023 | $ 0.00 | -$ 64M | $ 86M |
| 2022 | $ 13M | -$ 37M | $ 38M |
| IPO2021 | $ 6M | -$ 30M | $ 84M |
Explore beyond JSPR
You're looking at Jasper Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
